News

  Join us in making a difference: Sign up today and be a part of the solution! Let’s celebrate! We are thrilled to share a monumental milestone with you: OMF StudyME Registry has now surpassed 10,000 participants!   In April

Today, August 8, we unite to honor Severe ME/CFS Awareness Day. This year, we raise awareness through the lens of Whitney Dafoe. Whitney, son of Ron Davis, PhD, and Janet Dafoe, PhD, is an extraordinary soul whose ME/CFS journey has been

  In 2022, we set out to educate healthcare professionals about diagnosing and managing ME/CFS and other chronic complex diseases.   Today, we are thrilled to celebrate the successful completion of the second year of the Medical Education Resource Center

Imagine a life where your everyday dreams suddenly become a distant memory. For Erica, a vibrant young adult diagnosed with ME/CFS at just 14, the journey has been a relentless battle against fatigue, migraines, and cognitive dysfunction. Her aspirations for

We are overflowing with gratitude and hope following the incredible live-streaming event hosted by Dianna Cowern (Physics Girl) and her outstanding team. Your engagement and generosity have shattered our expectations. What started as a goal to raise $10,000 turned into

If you are a science enthusiast, you have probably heard of Dianna Cowern, an American science communicator and YouTuber known as Physics Girl, who is living with Long COVID and ME/CFS.  This Saturday (July 6, 2024), Dianna’s team will be

The Heart of the Matter In a recently released preprint, OMF’s computation team investigated the shared metabolic symptoms found in ME/CFS and Long COVID. Using new modeling technology, the team identified metabolic pathways that are dysregulated in both ME/CFS and

We are thrilled to announce that, as a direct outcome of the Canberra Roundtable convened in late March and led by Emerge Australia with the support of Open Medicine Foundation Australia, the Australian government has committed funding to update the

The Heart of the Matter   General practitioners (GPs) often trial different treatments with their ME/CFS and Long COVID patients.   In partnership with GPs, by studying the outcomes of each treatment, the patient’s lived experience, and the personal history